All Stories

  1. Decision-making after joint aspiration: C-reactive protein and synovial white blood cell count as laboratory indicators for surgical joint lavage in pediatric septic arthritis
  2. Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study
  3. Parvovirus-B19-Infektionen
  4. Sexuell übertragbare Infektionen
  5. Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis
  6. Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study
  7. Breastfeeding with HIV in a high-income setting: equipoise and beyond – time to question the zero-risk policy
  8. Impact of SARS-CoV-2 Pandemic on Pediatric Inpatients with Invasive Group A Streptococcal Infections (iGAS): Results of a National Survey
  9. Untargeted Metabolite Profile Associations With Body Mass Index, Waist–Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study
  10. Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers
  11. Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study
  12. Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop
  13. Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009–2022
  14. Diet Diversity and Adherence to a Mediterranean Diet Pattern in Pregnancy Is Protective Against the Development of Early-Childhood Atopic Dermatitis
  15. Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study
  16. Types of Myocardial Infarction in People With HIV in Switzerland
  17. Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017–2024 Time-series Analysis of National Data
  18. Outcomes After Prenatal Exposure to Raltegravir-Containing Antiretroviral Therapy: A Multicohort European Study
  19. Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022
  20. Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity
  21. Fluorescent Probe for the pH-Independent Rapid and Sensitive Direct Detection of Urease-Producing Bacteria
  22. Burden of post–acute COVID-19 sequelae in healthcare workers and its course over a 30-month period–results from a prospective multicentre cohort
  23. Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study
  24. Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study
  25. HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
  26. Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
  27. Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
  28. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis
  29. SARS‐CoV‐2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study
  30. Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis
  31. Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study
  32. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study
  33. Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter
  34. Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination – a retrospective cohort study
  35. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
  36. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort
  37. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
  38. Organ Dysfunction in Children With Blood Culture-Proven Sepsis: Comparative Performance of Four Scores in a National Cohort Study
  39. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study
  40. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies
  41. SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study
  42. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study
  43. Development of hybrid immunity during a period of high incidence of Omicron infections
  44. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
  45. Sensitivity of ICD coding for sepsis in children—a population-based study
  46. Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals (SURPRISE study)
  47. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
  48. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study
  49. Reply to Zeng and Zhou
  50. Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV
  51. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021): a longitudinal study in Switzerland
  52. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
  53. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
  54. The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model
  55. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry
  56. Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland – baseline findings from the first two years of the KIDS-STEP trial
  57. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
  58. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland
  59. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
  60. Implementation of an electronic, secure, web-based application to support routine hand hygiene observation with immediate direct feedback and anonymized benchmarking
  61. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
  62. Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
  63. Swiss recommendations on perioperative antimicrobial prophylaxis in children
  64. Lifestyle Behaviours of Children and Adolescents During the First Two Waves of the COVID-19 Pandemic in Switzerland and Their Relation to Well-Being: An Observational Study
  65. Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland
  66. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  67. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
  68. Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type
  69. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas
  70. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
  71. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
  72. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
  73. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
  74. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
  75. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
  76. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
  77. SwissPedData: Standardising hospital records for the benefit of paediatric research
  78. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
  79. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
  80. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
  81. Children living with HIV in Europe: do migrants have worse treatment outcomes?
  82. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  83. Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)
  84. Clinical data for paediatric research: the Swiss approach
  85. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study
  86. Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
  87. Maternal outcomes and risk factors for COVID-19 severity among pregnant women
  88. Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
  89. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
  90. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review
  91. The influence of human genetic variation on Epstein–Barr virus sequence diversity
  92. Leptospirosis Followed by Kawasaki-Like Disease: Case Report From an Adult Swiss Patient and Review of the Literature
  93. Can antibody tests accurately detect prior SARS-CoV-2 infection?
  94. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
  95. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland
  96. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study
  97. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
  98. Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study
  99. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
  100. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
  101. Swiss consensus recommendations on urinary tract infections in children
  102. Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
  103. Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
  104. Whole-exome sequencing for the identification of rare variants in primary immunodeficiency genes in children with sepsis - a prospective population-based cohort study
  105. Temporal Course of SARS‐CoV‐2 Antibody Positivity in Patients with COVID‐19 following the First Clinical Presentation
  106. SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2
  107. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
  108. Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
  109. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
  110. Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study
  111. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review
  112. Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy
  113. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales
  114. Time-to-Positivity of Blood Cultures in Children With Sepsis
  115. Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
  116. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
  117. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study
  118. Hand hygiene adherence in relation to influenza season during 6 consecutive years
  119. Akutes rheumatisches Fieber
  120. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
  121. Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
  122. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
  123. OUP accepted manuscript
  124. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland
  125. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland
  126. Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
  127. Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
  128. Syphilis: Diagnostik und Behandlung
  129. Primary cutaneous aspergillosis in a preterm neonate
  130. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung
  131. Mikrobiom – die Entdeckung eines Organs
  132. Postexpositionelle Prophylaxe (PEP) von HIV ausserhalb des Medizinalbereichs
  133. Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
  134. To Say or Not to Say: A Qualitative Study on the Disclosure of Their Condition by Human Immunodeficiency Virus–Positive Adolescents
  135. Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers
  136. Akutes Fieber beim Kleinkind
  137. Statin-induced immunomodulatory effects on human T cells in vivo
  138. Gynecomastia and potent antiretroviral therapy
  139. Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection
  140. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
  141. Sensitization to Human Immunodeficiency Virus in Seronegative Exposed Partners